Favorites Sign in

One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
  1. Home
  2. Companies
  3. Waters Corporation
  4. Financial Statements
Waters Corporation logo
Waters Corporation WAT
$ 436.95 0.65%
report update icon

Quarterly report 2026-Q2
added 08-11-2026

Waters Corporation Financial Statements 2025-2006 | WAT

Annual Financial Statements Waters Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006

Market Cap

 		19.7 B 22.5 B 19.7 B 18.8 B 19.7 B 16.4 B 15.5 B 17.8 B 17.1 B 11.4 B 9.98 B 10 B 9.38 B 8.09 B 7.84 B 6.24 B 4.29 B 6.07 B 6.04 B -

Shares

 		59.5 M 59.4 M 59.1 M 60 M 61.6 M 62.1 M 67.6 M 77 M 79.8 M 80.8 M 82.3 M 84.4 M 85.4 M 87.8 M 90.8 M 92.4 M 95.8 M 99.2 M 100 M -

Historical Prices

 		330 380 333 313 320 265 224 231 216 142 121 119 108 91.6 86.6 67.5 44.8 61.2 60.1 42.6

Net Income

 		643 M 638 M 642 M 708 M 693 M 522 M 592 M 594 M 20.3 M 522 M 469 M 432 M 450 M 461 M 433 M - 323 M 322 M 268 M -

Revenue

 		932 M 873 M 2.96 B 2.97 B 2.79 B 2.37 B 2.41 B 2.42 B 2.31 B 2.17 B 2.04 B 1.99 B 1.9 B 1.84 B 1.85 B - - - - -

Cost of Revenue

 		363 M 349 M 318 M 348 M 351 M 1.01 B 1.01 B 993 M 947 M 891 M 843 M 825 M 783 M 738 M 730 M 653 M 595 M 661 M 631 M -

Gross Profit

 		- - - - - - 1.4 B 1.43 B 1.36 B 1.28 B 1.2 B 1.16 B 1.12 B 1.11 B 1.12 B 990 M 904 M 914 M 842 M -

Operating Income

 		271 M 292 M 818 M 873 M 822 M 645 M 708 M 740 M 662 M 625 M 567 M 518 M 517 M 511 M 529 M 450 M 395 M 390 M 349 M -

Interest Expense

 		14.3 M 19 M 98.9 M 48.8 M 44.9 M 49.1 M 48.7 M 48.6 M 56.8 M 44.9 M 36.2 M 34.2 M 30 M 28.1 M 22 M 13.9 M 11 M 38.5 M -56.5 M -

EBITDA

 		359 M 379 M 902 M 945 M 893 M 714 M 718 M 747 M 680 M 638 M 582 M 529 M 527 M 533 M 538 M 484 M 426 M 419 M 376 M -

Operating Expenses

 		- - - - - - 687 M 688 M 689 M 648 M 628 M 647 M 603 M 587 M 592 M - - - - -

General and Administrative Expenses

 		240 M 173 M 736 M 658 M 627 M 554 M - - - - - - - - - 445 M 421 M 427 M 404 M -

All numbers in USD currency

Quarterly Income Statement Waters Corporation

2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1 2010-Q4 2010-Q3 2010-Q2 2010-Q1 2009-Q4 2009-Q3 2009-Q2

Shares

 		59.5 B 82.1 B 59.2 M 59.5 M 59.5 M 59.4 M 59.4 M 59.4 M 59.3 M 59.2 M 59.2 M 59.1 M 58.9 M 59 M 59.1 M 59.8 M - 60.6 M 60.7 M 61.4 M 61.7 M 62.3 M 62.2 M 62 M 61.9 M 62.2 M 63.8 M 66.2 M 69 M 71.7 M 74.8 M 76.6 M 77.8 M 78.9 M 79.5 M 79.7 M 80 M 80.1 M 80.4 M 80.7 M 80.8 M 81.3 M 81.6 M 82 M 82.6 M 83 M 83.2 M 83.7 M 84.5 M 85 M 85 M 85.2 M 85.5 M 86 M 86.7 M 87.4 M 88.3 M 89 M 89.3 M 90.7 M 91.7 M 91.6 M 97.3 M 91.7 M 92.6 M 93.6 M - 95.2 M 96.1 M

Net Income

 		147 M -72 M 102 M 149 M 147 M 121 M - 162 M 143 M 102 M - 135 M 151 M 141 M - 481 M - 160 M 216 M 477 M 167 M 148 M 218 M 303 M 176 M 53.6 M 201 M 392 M 253 M 109 M 185 M 409 M 268 M 112 M -353 M 373 M 237 M 106 M 174 M 125 M 128 M 94.1 M 151 M 116 M 106 M 96.1 M 151 M 113 M 96.5 M 70.3 M 142 M 98 M 89.3 M 121 M - - - - - - - - - - - 75.5 M - 75.9 M 69.9 M

Revenue

 		771 M 1.27 B 637 M 800 M 771 M 662 M - 740 M 709 M 637 M - 712 M 741 M 685 M - 709 M - 691 M 836 M 659 M 682 M 609 M 787 M 594 M 520 M 465 M 716 M 577 M 599 M 514 M 715 M 578 M 596 M 531 M 687 M 566 M 558 M 498 M 629 M 527 M 537 M 475 M 587 M 501 M 495 M 460 M 584 M 493 M 482 M 431 M 565 M 457 M 451 M 430 M 522 M 450 M 451 M 420 M 521 M 455 M 448 M 428 M - - - - - - -

Cost of Revenue

 		- - 262 M 164 M 164 M 152 M - - - - - - - - - - - - 351 M 271 M 280 M 254 M 321 M 262 M 213 M 211 M 299 M 241 M 250 M 221 M 287 M 241 M 243 M 221 M 270 M 236 M 230 M 211 M 252 M 218 M 220 M 201 M 238 M 207 M 209 M 189 M 233 M 202 M 202 M 188 M 229 M 192 M 188 M 175 M 208 M 183 M 179 M 167 M 204 M 180 M 176 M 170 M 127 M 163 M 155 M 146 M - 153 M 144 M

Gross Profit

 		- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 316 M 274 M 349 M 294 M 286 M 271 M 351 M 291 M 280 M 243 M 336 M 266 M 263 M 256 M 313 M 267 M 272 M 253 M 317 M 274 M 272 M 258 M 206 M 238 M 236 M 222 M - 221 M 219 M

Operating Income

 		188 M -47 M 134 M 192 M 188 M 152 M - 211 M 189 M 134 M - 179 M 200 M 174 M - 192 M - 195 M 262 M 192 M 196 M 171 M 264 M 158 M 155 M 68.3 M 236 M 173 M 178 M 121 M 245 M 172 M 179 M 144 M 231 M 159 M 154 M 119 M 208 M 152 M 152 M 113 M 181 M 136 M 130 M 120 M 172 M 139 M 118 M 88.8 M 176 M 119 M 113 M 109 M 159 M 122 M 120 M 110 M 165 M 127 M 121 M 116 M 85.5 M 104 M 106 M 92.4 M - 96.1 M 86.7 M

Interest Expense

 		-1 M 48 M 25.5 M 26.6 M 14.4 M 14.3 M - 21.4 M 23.7 M 25.5 M - 30.4 M 23.3 M 14.4 M - 12.4 M - 11.1 M 10.9 M 11.1 M 12 M 10.9 M 11.1 M 10.9 M 13 M 14.1 M 14.2 M 11.5 M 11.4 M 11.6 M 11.7 M 11.4 M 11.7 M 13.8 M 15.3 M 14.8 M 14.1 M 12.7 M 12.1 M 11.7 M 11 M 10.1 M 9.2 M 9.02 M 9.05 M 8.98 M 9.67 M 9.06 M 7.97 M 7.49 M 7.93 M 7.36 M 7.58 M 7.18 M 7.6 M 7.11 M 6.88 M 6.49 M 6.68 M 6.16 M 5.05 M 4.08 M 3.13 M 3.81 M 3.62 M -2.61 M - -2.86 M -2.65 M

EBITDA

 		217 M -11 M 134 M 222 M 217 M 173 M - 239 M 214 M 156 M - 205 M 218 M 194 M - 246 M - 213 M 262 M 245 M 196 M 188 M 264 M 208 M 188 M 84 M 236 M 215 M 206 M 133 M 245 M 216 M 210 M 160 M 231 M 204 M 185 M 132 M 208 M 191 M 178 M 125 M 181 M 169 M 153 M 131 M 172 M 173 M 136 M 97.6 M 176 M 147 M 131 M 118 M 159 M 149 M 137 M 118 M 165 M 155 M 139 M 125 M 85.5 M 130 M 123 M 101 M - 120 M 103 M

General and Administrative Expenses

 		198 M 387 M 175 M 214 M 201 M 175 M - 169 M 173 M 175 M - 187 M 187 M 182 M - 164 M - 157 M 173 M 153 M 158 M 143 M 153 M 135 M 117 M 148 M 141 M 126 M 133 M 134 M 143 M 127 M 137 M 130 M 148 M 135 M 130 M 131 M 130 M 124 M 130 M 129 M 129 M 125 M 123 M 120 M 132 M 122 M 132 M 127 M 131 M 121 M 123 M 119 M 122 M 115 M 123 M 117 M 126 M 121 M 125 M 117 M 99.2 M 111 M 107 M 107 M - 103 M 110 M

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Waters Corporation WAT
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Waters Corporation plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Diagnostics research industry

Issuer Price % 24h Market Cap Country
Enzo Biochem Enzo Biochem
ENZ
 		- -8.98 % $ 14.8 K usaUSA
Biomerica Biomerica
BMRA
 		$ 1.85 3.0 % $ 5.39 M usaUSA
Myriad Genetics Myriad Genetics
MYGN
 		$ 3.98 4.82 % $ 369 M usaUSA
Pacific Biosciences of California Pacific Biosciences of California
PACB
 		$ 1.73 0.73 % $ 519 M usaUSA
Neuronetics Neuronetics
STIM
 		$ 1.89 3.45 % $ 125 M usaUSA
Agilent Technologies Agilent Technologies
A
 		$ 172.97 0.07 % $ 49.1 B usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
 		$ 300.15 0.79 % $ 14.9 B usaUSA
Biodesix Biodesix
BDSX
 		$ 23.66 3.0 % $ 179 M usaUSA
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
 		$ 12.9 6.78 % $ 136 M chinaChina
Bioventus Bioventus
BVS
 		$ 13.3 0.94 % $ 886 M usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
 		- 0.22 % $ 16.8 M usaUSA
DermTech DermTech
DMTK
 		- -11.32 % $ 2.94 M usaUSA
Co-Diagnostics Co-Diagnostics
CODX
 		$ 0.65 11.61 % $ 865 K usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
 		$ 19.81 1.57 % $ 610 M usaUSA
Surmodics Surmodics
SRDX
 		- - $ 608 M usaUSA
Illumina Illumina
ILMN
 		$ 262.54 0.3 % $ 40.7 B usaUSA
Invitae Corporation Invitae Corporation
NVTA
 		- - $ 21.2 M usaUSA
Syneos Health Syneos Health
SYNH
 		- - $ 4.46 B usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
 		- -34.28 % $ 263 K israelIsrael
Renalytix AI plc Renalytix AI plc
RNLX
 		- 5.66 % $ 22.7 M britainBritain
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
 		$ 317.95 0.09 % $ 26.5 B usaUSA
Psychemedics Corporation Psychemedics Corporation
PMD
 		- -1.84 % $ 15.3 M usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
 		$ 99.7 0.03 % $ 6.73 B usaUSA
T2 Biosystems T2 Biosystems
TTOO
 		- -39.35 % $ 313 K usaUSA
Meridian Bioscience Meridian Bioscience
VIVO
 		- - $ 1.49 B usaUSA
Akumin Akumin
AKU
 		- -17.87 % $ 25.9 M canadaCanada
Accelerate Diagnostics Accelerate Diagnostics
AXDX
 		- -61.36 % $ 2.46 M usaUSA
Biocept Biocept
BIOC
 		- -13.05 % $ 7.29 M usaUSA
Anixa Biosciences Anixa Biosciences
ANIX
 		$ 2.67 4.71 % $ 86.7 K usaUSA
Medpace Holdings Medpace Holdings
MEDP
 		$ 618.47 1.94 % $ 17.8 B usaUSA
Heska Corporation Heska Corporation
HSKA
 		- - $ 1.31 B usaUSA
Celcuity Celcuity
CELC
 		$ 56.58 0.67 % $ 2.65 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
 		- -20.0 % $ 1.06 M usaUSA
Mettler-Toledo International Mettler-Toledo International
MTD
 		$ 1 622.29 0.12 % $ 33.4 B schweizSchweiz
NeoGenomics NeoGenomics
NEO
 		$ 16.65 2.19 % $ 2.13 B usaUSA
Neogen Corporation Neogen Corporation
NEOG
 		$ 11.81 0.73 % $ 2.57 B usaUSA
CareDx, Inc CareDx, Inc
CDNA
 		$ 64.0 3.07 % $ 3.41 B usaUSA
National Research Corporation National Research Corporation
NRC
 		$ 20.15 3.33 % $ 451 M usaUSA
Danaher Corporation Danaher Corporation
DHR
 		$ 229.04 3.04 % $ 163 B usaUSA
Koninklijke Philips N.V. Koninklijke Philips N.V.
PHG
 		$ 25.74 0.98 % $ 24.4 B niderlandNiderland
Brainsway Ltd. Brainsway Ltd.
BWAY
 		$ 11.44 2.69 % $ 389 M israelIsrael
Precipio Precipio
PRPO
 		$ 21.38 1.3 % $ 34.3 M usaUSA
RadNet RadNet
RDNT
 		$ 68.8 1.81 % $ 5.17 B usaUSA
Castle Biosciences Castle Biosciences
CSTL
 		$ 31.96 2.08 % $ 926 M usaUSA
Guardant Health Guardant Health
GH
 		$ 158.6 1.77 % $ 19.9 B usaUSA
Senseonics Holdings Senseonics Holdings
SENS
 		$ 7.77 1.6 % $ 324 M usaUSA
DarioHealth Corp. DarioHealth Corp.
DRIO
 		$ 4.82 0.97 % $ 19.2 M israelIsrael
DexCom DexCom
DXCM
 		$ 86.04 0.07 % $ 33.6 B usaUSA
IQVIA Holdings IQVIA Holdings
IQV
 		$ 266.9 0.11 % $ 45.9 B usaUSA
Quotient Limited Quotient Limited
QTNT
 		- -11.32 % $ 1.1 M schweizSchweiz